# FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

> clinical trial · VERIFIED · 2026-08-17

Status: RECRUITING · Sponsor: Tubulis GmbH · Condition: Ovarian Cancer

- Company: Tubulis GmbH
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06303505

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.